Correction: Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca(2+) release.

Li YJ, Guo MY, Qin WQ, Li JN, Li YF, Zhang FK, Xue XY, Li S, Qu JR, Liu RP, Wang L, Li XJ

Open source

DOI
10.1038/s41401-026-01963-x
Published
2026 Nov 9
Container
Acta pharmacologica Sinica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41401-026-01963-x,
  title = {Correction: Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca(2+) release.},
  author = {Li YJ and Guo MY and Qin WQ and Li JN and Li YF and Zhang FK and Xue XY and Li S and Qu JR and Liu RP and Wang L and Li XJ},
  year = {2026},
  journal = {Acta pharmacologica Sinica},
  doi = {10.1038/s41401-026-01963-x},
  url = {https://doi.org/10.1038/s41401-026-01963-x}
}

RIS

TY  - JOUR
TI  - Correction: Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca(2+) release.
AU  - Li YJ
AU  - Guo MY
AU  - Qin WQ
AU  - Li JN
AU  - Li YF
AU  - Zhang FK
AU  - Xue XY
AU  - Li S
AU  - Qu JR
AU  - Liu RP
AU  - Wang L
AU  - Li XJ
PY  - 2026
JO  - Acta pharmacologica Sinica
DO  - 10.1038/s41401-026-01963-x
UR  - https://doi.org/10.1038/s41401-026-01963-x
ER  - 

APA

YJ, L., MY, G., WQ, Q., JN, L., YF, L., FK, Z., XY, X., S, L., JR, Q., RP, L., L, W., & XJ, L. (2026). Correction: Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca(2+) release.. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01963-x

Source records